Unusual infections in humans.
Neafie RC, Marty AM.
Clin Microbiol Rev. 1993 Jan;6(1):34-56. doi: 10.1128/CMR.6.1.34.
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors.
Stienstra Y, van der Graaf WT, te Meerman GJ, The TH, de Leij LF, van der Werf TS.
Trop Med Int Health. 2001 Jul;6(7):554-62. doi: 10.1046/j.1365-3156.2001.00746.x.
Soft tissue lipoleiomyoma.
Scurry JP, Carey MP, Targett CS, Dowling JP.
Pathology. 1991 Oct;23(4):360-2. doi: 10.3109/00313029109063606.
Subcutaneous nodule on the scrotum.
Wobser M, Bauer B, Goebeler M.
J Dtsch Dermatol Ges. 2015 Feb;13(2):165-7. doi: 10.1111/ddg.12335. Epub 2014 Jul 29.
Cell therapy as a new approach on hepatic fibrosis of murine model of Schistosoma mansoni-infection.
Alsulami M, Abdel-Gaber R.
Acta Parasitol. 2021 Mar;66(1):136-145. doi: 10.1007/s11686-020-00267-2. Epub 2020 Aug 20.
The potential effects of silver and gold nanoparticles as molluscicides and cercaricides on Schistosoma mansoni.
Moustafa MA, Mossalem HS, Sarhan RM, Abdel-Rahman AA, Hassan EM.
Parasitol Res. 2018 Dec;117(12):3867-3880. doi: 10.1007/s00436-018-6093-2. Epub 2018 Oct 3.
Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice.
El-Agamy DS, Shebl AM, Said SA.
Inflammopharmacology. 2011 Dec;19(6):307-16. doi: 10.1007/s10787-011-0092-6. Epub 2011 Sep 23.
Schistosoma mansoniToxoplasma gondii-Induced Crohn's-Like Ileitis by Preserving the Epithelial Barrier and Downregulating the Inflammatory Response.
Pêgo B, Martinusso CA, Bernardazzi C, Ribeiro BE, de Araujo Cunha AF, de Souza Mesquita J, Nanini HF, Machado MP, Castelo-Branco MTL, Cavalcanti MG, de Souza HSP.
Front Immunol. 2019 Mar 18;10:442. doi: 10.3389/fimmu.2019.00442. eCollection 2019.
Histopathological study of the attrition of challenge cercariae of Schistosoma mansoni in the skin of mice immunized by chronic infection and by use of highly X-irradiated cercariae.
Hsü SY, Hsü HF, Johnson SC, Xu ST, Johnson SM.
Z Parasitenkd. 1983;69(5):627-42. doi: 10.1007/BF00926673.
Antieosinophil serum and the kinetics of eosinophilia in Schistosomiasis mansoni.
Mahmoud AA, Warren KS, Graham RC Jr.
J Exp Med. 1975 Sep 1;142(3):560-74. doi: 10.1084/jem.142.3.560.
